Clinical Scorecard: Comparative Analysis of Efficacy and Safety Between Hypofractionated and Conventional Radiotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Breast Cancer
Key Mechanisms
Comparison of hypofractionated whole-breast irradiation (HFRT) versus conventional fractionated radiotherapy (CFRT) in terms of disease-free survival and treatment-related toxicities.
Target Population
Adult patients with early-stage breast cancer receiving radiotherapy following surgery.
Care Setting
Oncology clinics and hospitals providing radiotherapy.
Key Highlights
HFRT shows comparable disease-free survival to CFRT (RR = 1.01, P = 0.83).
No significant difference in lymphedema incidence between HFRT and CFRT (RR = 1.19, P = 0.15).
HFRT may reduce acute radiation dermatitis compared to CFRT (RR = 1.62, P = 0.002).
High heterogeneity across studies warrants cautious interpretation of results.
Standardization of radiation treatments is recommended for future research.
Guideline-Based Recommendations
Diagnosis
Utilize imaging and histopathological evaluation for breast cancer diagnosis.
Management
Consider HFRT as a standard treatment option for early-stage breast cancer post-surgery.
Monitoring & Follow-up
Regular follow-up for disease-free survival and assessment of treatment-related toxicities.
Risks
Monitor for acute radiation dermatitis and lymphedema as potential side effects.
Patient & Prescribing Data
Adult women with early-stage breast cancer.
HFRT offers similar oncological outcomes to CFRT with potentially reduced acute toxicity.
Clinical Best Practices
Adopt hypofractionated regimens for eligible patients to shorten treatment duration.
Ensure comprehensive patient education regarding potential side effects.
Standardize treatment protocols to minimize variability in clinical practice.
by Malek Talal, Marafi Jammaa Ahmed, Muhammad M. Elsharkawy, Alaa R. AL-Ihribat, Mohamed F. Srour, Youssef Z. Farhat, Muhammad Youssef, Rabeia Babiker Mustafa, Mohamed Wafa, Ahmed Werdany Hassan, Aya Ahmed Shimal, Omran Shrebaty, Ibrahim Moqbel
